Product NDC: | 45802-717 |
Proprietary Name: | Terconazole |
Non Proprietary Name: | Terconazole |
Active Ingredient(s): | 80 mg/1 & nbsp; Terconazole |
Administration Route(s): | VAGINAL |
Dosage Form(s): | SUPPOSITORY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-717 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077149 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060828 |
Package NDC: | 45802-717-08 |
Package Description: | 1 BLISTER PACK in 1 CARTON (45802-717-08) > 3 SUPPOSITORY in 1 BLISTER PACK |
NDC Code | 45802-717-08 |
Proprietary Name | Terconazole |
Package Description | 1 BLISTER PACK in 1 CARTON (45802-717-08) > 3 SUPPOSITORY in 1 BLISTER PACK |
Product NDC | 45802-717 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terconazole |
Dosage Form Name | SUPPOSITORY |
Route Name | VAGINAL |
Start Marketing Date | 20060828 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | TERCONAZOLE |
Strength Number | 80 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |